Peter Baker @peterbakernyt
As of last year, there were 70 potential Alzheimer's therapies in clinical trials and 22 targeting amyloid compared with 1,100 for cancer, 445 for other neurological diseases and 200 for heart disease and stroke. @PostRowland https://t.co/a9vTxfpF30 — PolitiTweet.org